Neurocrine Biosciences, Inc. (NBIX)
138.41
-2.03
(-1.45%)
USD |
NASDAQ |
Sep 29, 16:00
138.41
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Price : 138.41 for Sept. 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | 137.76 | 140.59 | 136.78 | 140.44 | 1.432M |
| Sep 25, 2026 | 138.94 | 138.94 | 137.02 | 138.40 | 1.171M |
| Sep 24, 2026 | 138.54 | 140.63 | 137.00 | 138.94 | 1.169M |
| Sep 23, 2026 | 141.97 | 142.24 | 139.32 | 139.49 | 1.748M |
| Sep 22, 2026 | 144.17 | 144.26 | 141.78 | 142.25 | 1.214M |
| Sep 21, 2026 | 146.15 | 146.26 | 143.45 | 143.96 | 1.385M |
| Sep 18, 2026 | 152.63 | 152.63 | 146.06 | 146.23 | 2.816M |
| Sep 17, 2026 | 151.14 | 152.06 | 149.71 | 151.83 | 1.178M |
| Sep 16, 2026 | 150.34 | 151.31 | 149.00 | 149.50 | 1.016M |
| Sep 15, 2026 | 156.70 | 156.70 | 149.15 | 150.02 | 1.332M |
| Sep 14, 2026 | 158.00 | 159.19 | 156.57 | 157.22 | 785561.0 |
| Sep 11, 2026 | 157.20 | 159.67 | 156.12 | 156.22 | 890877.0 |
| Sep 10, 2026 | 154.38 | 159.94 | 152.04 | 156.57 | 895198.0 |
| Sep 09, 2026 | 154.61 | 155.55 | 152.38 | 155.14 | 1.051M |
| Sep 08, 2026 | 153.99 | 156.82 | 151.77 | 155.13 | 820811.0 |
| Sep 04, 2026 | 158.24 | 159.80 | 154.83 | 155.64 | 933570.0 |
| Sep 03, 2026 | 159.93 | 159.93 | 156.76 | 158.35 | 758263.0 |
| Sep 02, 2026 | 157.39 | 160.42 | 155.09 | 157.79 | 1.038M |
| Sep 01, 2026 | 154.31 | 157.03 | 153.70 | 156.76 | 878439.0 |
| Aug 31, 2026 | 153.11 | 155.00 | 151.77 | 154.03 | 1.741M |
| Aug 28, 2026 | 155.92 | 156.57 | 153.08 | 154.06 | 812988.0 |
| Aug 27, 2026 | 155.28 | 156.75 | 154.61 | 155.92 | 730293.0 |
| Aug 26, 2026 | 153.21 | 159.40 | 152.02 | 156.59 | 1.119M |
| Aug 25, 2026 | 153.84 | 156.13 | 152.00 | 153.37 | 1.042M |
| Aug 24, 2026 | 152.57 | 154.56 | 151.77 | 153.04 | 1.208M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 13.16 |
| Liquidia Corp. | 70.67 |
| BioCryst Pharmaceuticals, Inc. | 8.26 |
| Halozyme Therapeutics, Inc. | 111.54 |
| Iovance Biotherapeutics, Inc. | 14.44 |
Price Related Metrics
| PE Ratio | 20.28 |
| PS Ratio | 4.244 |
| PEG Ratio | 0.1999 |
| Price to Book Value | 3.807 |
| Price to Free Cash Flow | 17.63 |
| Earnings Yield | 4.93% |
| Market Cap | 14.06B |
| PEGY Ratio | 0.1999 |
| Operating PE Ratio | 17.76 |
| Normalized PE Ratio | 20.69 |